Details for Patent: 6,177,101
✉ Email this page to a colleague
Summary for Patent: 6,177,101
| Title: | Delavirdine high strength tablet formulation |
| Abstract: | Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the group consisting of a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40% where the rapidly precipitating drug, "binder" and superdisintegrant are mixed and compressed into a tablet without heating, solvent or grinding. |
| Inventor(s): | Alice C. Martino, Ashley H. Bates, Walter Morozowich, E. John Lee |
| Assignee: | Pharmacia and Upjohn Co LLC |
| Application Number: | US09/327,135 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; Dosage form; |
Drugs Protected by US Patent 6,177,101
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,177,101
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 349203 | ⤷ Start Trial | |||
| Australia | 4213499 | ⤷ Start Trial | |||
| Australia | 753241 | ⤷ Start Trial | |||
| Brazil | 9910481 | ⤷ Start Trial | |||
| Canada | 2328703 | ⤷ Start Trial | |||
| China | 1237958 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
